The award-winning professionals were: M.ª Ángeles Ibarrondo, director of Health Research and Innovation of the Basque Country; María A. Blasco, Scientific Director of the Spanish National Cancer Research Centre (CNIO); Susana Marcos, Director of the Visual Optics and Biophotonics Laboratory of the Optics Institute of the Spanish National Research Council (CSIC); Gema Climent, R&D Director…
On Tuesday, July 4th, Mikrobiomik, a biotechnology company, was honored with the “SMEs Bizkaia” award in the category of Social Responsibility. In a high standard competition with 1800 other SMEs, Mikrobiomik presented its project at the contest sponsored by Banco Santander. Its revolutionary proposal is based on a biological drug developed from intestinal microbiota, still…
The Basque biopharmaceutical company, a specialist in the design and distribution of bioreagents for scientific research, offers to the research community a new solution to obtain quality custom-made polyclonal antibodies at a reduced cost. Thanks to the standardization of polyclonal antibody production and purification processes, it is possible to reduce costs without losing the…
Inscription Description: The “8th Biosalud New Aquitaine – Basque Country – Navarra Biosalud Meetings”, will take place at the Medical College of Pamplona (Spain), on 16 and 17 October 2023. The aim of the meetings is to boost the bio-health sector in the Euroregion and to promote Euroregional collaboration. The Meetings are aimed at companies,…
VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is currently working on more than 40 international projects in compliance with FDA and EMA regulations, and is manufacturing vectors for companies based in the US, Europe, Asia and Australia. VIVEbiotech is authorized to manufacture lentiviral vectors…
VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is currently working on more than 40 international projects in compliance with FDA and EMA regulations, and is manufacturing vectors for companies based in the US, Europe, Asia and Australia. VIVEbiotech is authorized to manufacture lentiviral vectors…
The European MACRAMÉ project is working on the development of methodologies to detect, characterise and quantify advanced materials during their handling and transformation throughout the product life cycle. Zamudio, 11 July 2023. The GAIKER Technology Centre, a member of the Basque Research & Technology Alliance, BRTA, is one of the 19 partners that make…
Following the success of the “Expert Course in Regulatory Affairs 2022-2023” regarding the new Regulations on medical devices (MP) and in vitro diagnostic (IVD) medical devices under the new European Regulations (EU) 2017/745 and 2017/746 of the European Parliament and of the Council of 5 April 2017 on this type of products, the Basque Health…
The agreement signed by the national employers’ association of the Healthcare Technology Sector and the Basque Association of Biosciences and Health will promote projects that strengthen the innovative industrial fabric, entrepreneurship and the value of data. The initiatives will involve different agents in the healthcare value chain: companies, SMEs, corporations and healthcare institutions, scientific-technological entities…
We are pleased to announce and welcome four new entities to join our community of innovation and collaboration. Their experience and expertise add to our growth and strengthening as a cluster. We thank Aleovitro, DNA Data, Hospital San Juan de Dios and Vithas for joining us and trusting in the potential of our cluster to…
